DiNuzzo Private Wealth
ACAD icon

DiNuzzo Private Wealth’s Acadia Pharmaceuticals ACAD Stock Holding History

DiNuzzo Private Wealth’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$323 Sell
16
-4
-20% -$107 ﹤0.01% 1196
2026
Q2 		$506 Buy
20
+5
+33% +$110 ﹤0.01% 1098
2026
Q1 		$334 Hold
15
– – ﹤0.01% 1174
2025
Q4 		$401 Buy
15
+3
+25% +$72 ﹤0.01% 1141
2025
Q3 		$312 Buy
+12
New +$284 ﹤0.01% 1194

Other funds holding ACAD

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

DiNuzzo Private Wealth's ACAD Position: Q3 2026 in Review

DiNuzzo Private Wealth reduced its Acadia Pharmaceuticals (ACAD) stake by 20% in Q3 2026, selling an estimated $107 and leaving 16 shares worth $323. The position accounts for ﹤0.01% of the portfolio, ranked #1196.

DiNuzzo Private Wealth first reported a position in ACAD in Q3 2025 and has held it in 5 quarters since. The position peaked at $506 in Q2 2026. 71 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • DiNuzzo Private Wealth held 16 shares of Acadia Pharmaceuticals worth $323 as of Q3 2026.
  • DiNuzzo Private Wealth sold 4 Acadia Pharmaceuticals shares in Q3 2026, an estimated $107.
  • Acadia Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #1196 holding.
  • DiNuzzo Private Wealth first reported a position in Acadia Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • DiNuzzo Private Wealth's Acadia Pharmaceuticals position peaked at $506 in Q2 2026.
  • 71 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.